newsfilter
← Latest News
GlobeNewswire·

Talaris Therapeutics Announces Closing of Initial Public Offering

BOSTON and LOUISVILLE, Ky. , May 11, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (NASDAQ:TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation,